Inventor · disambiguated record
Christopher C. Arico-Muendel
Also filed as: ARICO-MUENDEL CHRISTOPHER C
16 granted patents·8 pending applications·475 citations·filing 1996–2011
95Inventor score
Files withPRAECIS PHARM INC17MORGAN BARRY3GLAXOSMITHKLINE LLC2BENJAMIN DENNIS1PARAECIS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
24 records- 0195US7084108B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2001·Granted Aug 1, 2006·72 cites·27 claims
- 0292US6303567B1Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1996·Granted Oct 16, 2001·142 cites·135 claims
- 0392US5985242AModulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1997·Granted Nov 16, 1999·120 cites·19 claims
- 0491US7348307B2Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2006·Granted Mar 25, 2008·9 cites·71 claims
- 0590US7989395B2Methods for identifying compounds of interest using encoded librariesGLAXOSMITHKLINE LLC·Filed 2006·Granted Aug 2, 2011·15 cites·46 claims
- 0686US7972994B2Methods for synthesis of encoded librariesGLAXOSMITHKLINE LLC·Filed 2006·Granted Jul 5, 2011·9 cites·43 claims
- 0786US7935658B2Methods for synthesis of encoded librariesPRAECIS PHARM INC·Filed 2007·Granted May 3, 2011·9 cites·40 claims
- 0885US6689752B2Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 2001·Granted Feb 10, 2004·17 cites·21 claims
- 0984US7105482B2Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2003·Granted Sep 12, 2006·14 cites·43 claims
- 1084US6277826B1Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1999·Granted Aug 21, 2001·36 cites·11 claims
- 1182US7405194B2Therapeutic agents and methods of use thereof for the treatment of melanomaPRAECIS PHARM INC·Filed 2006·Granted Jul 29, 2008·4 cites·71 claims
- 1280US7972992B2Methods for synthesis of encoded librariesPRAECIS PHARM INC·Filed 2004·Granted Jul 5, 2011·10 cites·35 claims
- 1379US7175828B2Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 2003·Granted Feb 13, 2007·4 cites·13 claims
- 1479US7157420B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2004·Granted Jan 2, 2007·10 cites·46 claims
- 1572US8410028B2Methods for synthesis of encoded librariesMORGAN BARRY·Filed 2011·Granted Apr 2, 2013·3 cites·64 claims
- 1667US8598089B2Methods for synthesis of encoded librariesMORGAN BARRY·Filed 2011·Granted Dec 3, 2013·1 cites·3 claims
- 1761US2009156624A1Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2008·Application pending·0 cites
- 1857US2007117758A1Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 1955US2007248996A1Modulators of beta-amyloid peptide aggregation comprising D-amino acidsPARAECIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2053US2011136697A1Methods for synthesis of encoded librariesPRAECIS PHARM INC·Filed 2011·Application pending·0 cites
- 2147US2005239878A1Inhibitors of methionine aminopeptidase-2 and uses thereofPRAECIS PHARM INC·Filed 2004·Application pending·0 cites
- 2246US2007161570A1Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 2345US2012071329A1Methods for identifying compounds of interest using encoded librariesMORGAN BARRY·Filed 2011·Application pending·0 cites
- 2444US2004265917A1Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subjectBENJAMIN DENNIS·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher C. Arico-Muendel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →